Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SMMT Summit Therapeutics PLC

未开盘 07-08 16:00:00 EDT

22.99

+0.38

+1.68%

盘后22.88

-0.11-0.48%

19:50 EDT

最高23.02	最低22.16	成交量298.80万
今开22.70	昨收22.61	日振幅3.80%
总市值170.74亿	流通市值26.68亿	总股本7.43亿
成交额6,782万	换手率2.57%	流通股本1.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SMMT","market":"US","secType":"STK","nameCN":"Summit Therapeutics PLC","latestPrice":22.99,"timestamp":1752004800000,"preClose":22.61,"halted":0,"volume":2988012,"hourTrading":{"tag":"盘后","latestPrice":22.88,"preClose":22.99,"latestTime":"19:50 EDT","volume":28857,"amount":662281.4644,"timestamp":1752018603261},"delay":0,"floatShares":116053061,"shares":742665924,"eps":-0.339558,"marketStatus":"未开盘","change":0.38,"latestTime":"07-08 16:00:00 EDT","open":22.7,"high":23.02,"low":22.16,"amount":67815346.653696,"amplitude":0.038036,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.339558,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752048000000},"marketStatusCode":0,"adr":1,"adrRate":5,"listingDate":1425531600000,"exchange":"NASDAQ","adjPreClose":22.61,"preHourTrading":{"tag":"盘前","latestPrice":22.72,"preClose":22.61,"latestTime":"09:29 EDT","volume":12072,"amount":276719.478384,"timestamp":1751981399999},"postHourTrading":{"tag":"盘后","latestPrice":22.88,"preClose":22.99,"latestTime":"19:50 EDT","volume":28857,"amount":662281.4644,"timestamp":1752018603261},"volumeRatio":0.594885,"impliedVol":0.9449,"impliedVolPercentile":0.684},"requestUrl":"/m/hq/s/SMMT","defaultTab":"news","newsList":[{"id":"2546777939","title":"暴跌超55%！关税，冲击显现！","url":"https://stock-news.laohu8.com/highlight/detail?id=2546777939","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546777939?lang=zh_cn&edition=full","pubTime":"2025-06-28 18:58","pubTimestamp":1751108280,"startTime":"0","endTime":"0","summary":"关税对全球汽车产业的冲击，正逐步显现！另外，数据显示，5月份，英国对美国市场的汽车出口量同比下跌55.4%，对欧盟市场的汽车出口量同比下跌22.5%。当地时间3月26日，美国总统特朗普在白宫签署行政令，宣布对所有进口汽车征收25%关税，相关措施于4月2日生效。根据协议，这些关税调整将于6月30日凌晨0时1分生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-06-28/doc-infcrsef1372858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SMMT","LU2488822045.USD","BK4139"],"gpt_icon":0},{"id":"2539220915","title":"Summit Therapeutics报告了 Ivonescimab在肺癌治疗中的混合试验结果Summit Therapeutics Reports Mixed Trial Results for Ivonescimab in Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2539220915","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539220915?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:10","pubTimestamp":1748610600,"startTime":"0","endTime":"0","summary":"by Mark Chiang马克·蒋Share To分享到Summit Therapeutics announced mixed results from a recent trial of its antibody treatment for lung cancer, Ivonescimab. The drug, which had previously outperformed Merck’s Keytruda in a direct comparison study, was closely monitored in this latest evaluation. The findings revealed both promising and less favorable outcomes, raising questions about its overall efficacy..Summit Therapeutics 近期对其用于治疗肺癌的抗体药物Ivonescimab进行的试验宣布了好坏参半的结果。The trial aimed to further assess Ivonescimab’s effectiveness as a treatment option for lung cancer patients. While the drug demonstrated certain advantages over existing therapies in specific areas, other aspects of the study showed less encouraging results. Summit Therapeutics has not yet disclosed detailed data from the trial but confirmed that the results were varied.该试验旨在进一步评估Ivonescimab作为肺癌患者治疗方案的有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530211531976b3081&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530211531976b3081&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU2488822045.USD","SMMT","LENZ","BK4539","BK4007"],"gpt_icon":1},{"id":"2539222123","title":"Summit(SMMT.US)与康方生物合作药物3期试验获积极结果，有望冲刺FDA申报","url":"https://stock-news.laohu8.com/highlight/detail?id=2539222123","media":"智通财经","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539222123?lang=zh_cn&edition=full","pubTime":"2025-05-30 20:26","pubTimestamp":1748607982,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国生物技术公司Summit Therapeutics周五宣布，其与中国合作伙伴康方生物合作开发的主要资产ivonescimab在肺癌联合治疗方案的临床试验中达成了主要目标。关于耐受性，Summit表示，HARMONi试验未显示出新的安全性信号，在接受ivonescimab+化疗治疗的患者中约有57%出现了3级或以上的治疗相关不良事件，而对照组中该比例约为50%。该结果与康方生物在中国开展的HARMONi-A试验结果一致，该试验促成了中国监管机构去年批准ivonescimab联合化疗用于肺癌治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1299884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B543WZ88.USD","LU0348783233.USD","BK4139","IE00BPRC5H50.USD","BK1161","BK1574","LU1720050803.USD","LU0348784397.USD","SMMT","LU0417516571.SGD","LU1794554557.SGD","LU2488822045.USD","09926","IE00B5MMRT66.SGD"],"gpt_icon":1},{"id":"2537610691","title":"Summit Therapeutics Inc.5月23日成交额为4529.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537610691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537610691?lang=zh_cn&edition=full","pubTime":"2025-05-24 11:57","pubTimestamp":1748059034,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日，Summit Therapeutics Inc.成交额为4529.87万美元，成交额较昨日减少40.17%，当日成交量为175.91万股。Summit Therapeutics Inc.于2025年5月23日涨0.31%，报25.85美元，该股过去5个交易日涨8.29%，年初至今涨44.82%，过去60日涨39.81%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-23|4529.87万|-40.17%|175.91万|#|2025-05-22|7571.47万|-32.50%|293.41万|#|2025-05-21|1.12亿|153.19%|440.94万|#|2025-05-20|4430.44万|17.82%|183.99万|#|2025-05-19|3760.40万|-3.71%|159.90万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524115723a48a69e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524115723a48a69e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SMMT","BK4007","LENZ","BK4139","LU2488822045.USD"],"gpt_icon":0},{"id":"2537960406","title":"Summit Therapeutics Inc.5月21日成交额为1.12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537960406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537960406?lang=zh_cn&edition=full","pubTime":"2025-05-22 11:57","pubTimestamp":1747886242,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日，Summit Therapeutics Inc.成交额为1.12亿美元，成交额较昨日增加153.19%，当日成交量为440.94万股。Summit Therapeutics Inc.于2025年5月21日涨4.18%，报25.41美元，该股过去5个交易日涨11.69%，年初至今涨42.35%，过去60日涨40.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-21|1.12亿|153.19%|440.94万|#|2025-05-20|4430.44万|17.82%|183.99万|#|2025-05-19|3760.40万|-3.71%|159.90万|#|2025-05-16|3905.15万|-37.02%|165.72万|#|2025-05-15|6200.99万|-31.34%|274.68万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522115731a487a341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522115731a487a341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SMMT","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2536665055","title":"Summit Therapeutics Inc.5月19日成交额为3760.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536665055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536665055?lang=zh_cn&edition=full","pubTime":"2025-05-20 11:36","pubTimestamp":1747712168,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日，Summit Therapeutics Inc.成交额为3760.40万美元，成交额较昨日减少3.71%，当日成交量为159.90万股。Summit Therapeutics Inc.于2025年5月19日涨0.59%，报24.01美元，该股过去5个交易日跌4.95%，年初至今涨34.51%，过去60日涨8.54%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-19|3760.40万|-3.71%|159.90万|#|2025-05-16|3905.15万|-37.02%|165.72万|#|2025-05-15|6200.99万|-31.34%|274.68万|#|2025-05-14|9031.37万|79.12%|390.21万|#|2025-05-13|5041.94万|-32.73%|204.53万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520113618a6e57c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520113618a6e57c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SMMT","BK4139","BK4007","LU2488822045.USD","LENZ"],"gpt_icon":0},{"id":"2534144241","title":"Summit Therapeutics Inc.5月8日成交额为7158.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534144241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534144241?lang=zh_cn&edition=full","pubTime":"2025-05-09 10:48","pubTimestamp":1746758935,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日，Summit Therapeutics Inc.成交额为7158.12万美元，成交额较昨日减少8.53%，当日成交量为287.92万股。Summit Therapeutics Inc.于2025年5月8日涨1.48%，报24.65美元，该股过去5个交易日跌0.08%，年初至今涨38.1%，过去60日涨29.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-08|7158.12万|-8.53%|287.92万|#|2025-05-07|7825.74万|-28.34%|323.44万|#|2025-05-06|1.09亿|42.04%|439.96万|#|2025-05-05|7688.60万|-63.12%|277.41万|#|2025-05-02|2.08亿|138.06%|735.45万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509104904a47787b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509104904a47787b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","SMMT","LU2488822045.USD"],"gpt_icon":0},{"id":"2534211804","title":"英美协议的意义：10%关税是特朗普底线，汽车关税调整或成模版","url":"https://stock-news.laohu8.com/highlight/detail?id=2534211804","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534211804?lang=zh_cn&edition=full","pubTime":"2025-05-09 09:35","pubTimestamp":1746754500,"startTime":"0","endTime":"0","summary":"英国对美国的出口仍将面临最低10%的关税，远高于2023年不到2%的水平。分析称，如果英国都无法降至零关税，那么其他国家几乎不可能做到。英美贸易协议将英国汽车进口到美国的额外25%关税降至最高10%，并设置每年10万辆汽车的上限。这或成为欧盟、日本、韩国等国关税谈判的模版。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3746750","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3746750","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2488822045.USD","SMMT"],"gpt_icon":0},{"id":"2533912064","title":"Summit Therapeutics Inc.5月7日成交额为7825.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533912064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533912064?lang=zh_cn&edition=full","pubTime":"2025-05-08 10:41","pubTimestamp":1746672093,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日，Summit Therapeutics Inc.成交额为7825.74万美元，成交额较昨日减少28.34%，当日成交量为323.44万股。Summit Therapeutics Inc.于2025年5月7日涨0.37%，报24.29美元，该股过去5个交易日涨0.7%，年初至今涨36.08%，过去60日涨18.49%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-07|7825.74万|-28.34%|323.44万|#|2025-05-06|1.09亿|42.04%|439.96万|#|2025-05-05|7688.60万|-63.12%|277.41万|#|2025-05-02|2.08亿|138.06%|735.45万|#|2025-05-01|8757.17万|-16.22%|355.61万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508104144a4761543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508104144a4761543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU2488822045.USD","BK4139","LENZ","SMMT"],"gpt_icon":0},{"id":"2532071158","title":"Summit Therapeutics Inc.5月2日成交额为2.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532071158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532071158?lang=zh_cn&edition=full","pubTime":"2025-05-03 10:36","pubTimestamp":1746239819,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日，Summit Therapeutics Inc.成交额为2.08亿美元，成交额较昨日增加138.06%，当日成交量为735.45万股。Summit Therapeutics Inc.于2025年5月2日涨13.09%，报27.9美元，该股过去5个交易日涨18.88%，年初至今涨56.3%，过去60日涨34.26%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-02|2.08亿|138.06%|735.45万|#|2025-05-01|8757.17万|-16.22%|355.61万|#|2025-04-30|1.05亿|3.91%|437.53万|#|2025-04-29|1.01亿|-69.15%|422.98万|#|2025-04-28|3.26亿|-49.88%|1310.29万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503103709a6d1a3fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503103709a6d1a3fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SMMT","LU2488822045.USD","LENZ","BK4139"],"gpt_icon":1},{"id":"2532208828","title":"高盛：维持Summit Therapeutics(SMMT.US)评级，由买入调整至买入评级, 目标价由37.00美元调整至41.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532208828","media":"金融界","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532208828?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:14","pubTimestamp":1746206066,"startTime":"0","endTime":"0","summary":"高盛：维持Summit Therapeutics(SMMT.US)评级，由买入调整至买入评级, 目标价由37.00美元调整至41.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03011450110421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SMMT","LENZ"],"gpt_icon":0},{"id":"1141030630","title":"异动解读 | Summit Therapeutics盘中大涨6.61%，分析师看好前景尽管季报亏损扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=1141030630","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141030630?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:44","pubTimestamp":1746193441,"startTime":"0","endTime":"0","summary":"生物制药公司Summit Therapeutics今日盘中大涨6.61%，引起投资者广泛关注。尽管公司最新季报显示亏损扩大，但分析师对其前景仍持乐观态度，这似乎是推动股价上涨的主要因素。根据公司发布的截至2025年3月31日的季度财报，Summit Therapeutics当季每股亏损45美分，远低于分析师预期的9美分亏损，也显著高于去年同期6美分的亏损。值得注意的是，尽管业绩不佳，分析师仍对Summit Therapeutics保持乐观态度。华尔街对Summit Therapeutics未来12个月的目标价中位数为36.00美元，远高于当前股价。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SMMT"],"gpt_icon":0},{"id":"1194707295","title":"异动解读 | Summit Therapeutics盘前大涨5.15%，尽管季报亏损扩大但获分析师看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1194707295","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194707295?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:30","pubTimestamp":1746192646,"startTime":"0","endTime":"0","summary":"生物制药公司Summit Therapeutics今日盘前大涨5.15%，引起投资者关注。尽管公司最新季报显示亏损扩大，但分析师对其前景持乐观态度。根据公司发布的截至2025年3月31日的季度财报，Summit Therapeutics当季每股亏损45美分，远低于分析师预期的9美分亏损，也显著高于去年同期6美分的亏损。值得注意的是，尽管业绩不佳，分析师仍对Summit Therapeutics保持乐观态度。华尔街对Summit Therapeutics未来12个月的目标价中位数为36.00美元，远高于当前股价。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Summit Therapeutics盘前大涨5.15%，尽管季报亏损扩大但获分析师看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SMMT"],"gpt_icon":0},{"id":"2532048749","title":"Summit Therapeutics Inc.4月30日成交额为1.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532048749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532048749?lang=zh_cn&edition=full","pubTime":"2025-05-01 10:37","pubTimestamp":1746067074,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，Summit Therapeutics Inc.成交额为1.05亿美元，成交额较昨日增加3.91%，当日成交量为437.53万股。Summit Therapeutics Inc.于2025年4月30日涨2.12%，报24.12美元，该股过去5个交易日跌27.41%，年初至今涨35.13%，过去60日涨20.72%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-30|1.05亿|3.91%|437.53万|#|2025-04-29|1.01亿|-69.15%|422.98万|#|2025-04-28|3.26亿|-49.88%|1310.29万|#|2025-04-25|6.51亿|144.40%|2467.05万|#|2025-04-24|2.66亿|-28.81%|762.62万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501103759a46e7325&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501103759a46e7325&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","BK4007","LU2488822045.USD","LENZ","BK4139"],"gpt_icon":1},{"id":"2531725131","title":"Summit Therapeutics Inc.4月29日成交额为1.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531725131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531725131?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:36","pubTimestamp":1745980584,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Summit Therapeutics Inc.成交额为1.01亿美元，成交额较昨日减少69.15%，当日成交量为422.98万股。Summit Therapeutics Inc.于2025年4月29日跌2.03%，报23.62美元，该股过去5个交易日跌13.64%，年初至今涨32.32%，过去60日涨9.86%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|1.01亿|-69.15%|422.98万|#|2025-04-28|3.26亿|-49.88%|1310.29万|#|2025-04-25|6.51亿|144.40%|2467.05万|#|2025-04-24|2.66亿|-28.81%|762.62万|#|2025-04-23|3.74亿|199.84%|1179.65万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430103630a6ce2cf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430103630a6ce2cf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LU2488822045.USD","LENZ","BK4139","BK4007"],"gpt_icon":1},{"id":"2531921745","title":"Summit Therapeutics Inc.4月28日成交额为3.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531921745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531921745?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:34","pubTimestamp":1745894066,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，Summit Therapeutics Inc.成交额为3.26亿美元，成交额较昨日减少49.88%，当日成交量为1310.29万股。Summit Therapeutics Inc.于2025年4月28日涨2.75%，报24.11美元，该股过去5个交易日跌4.4%，年初至今涨35.07%，过去60日涨7.83%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-28|3.26亿|-49.88%|1310.29万|#|2025-04-25|6.51亿|144.40%|2467.05万|#|2025-04-24|2.66亿|-28.81%|762.62万|#|2025-04-23|3.74亿|199.84%|1179.65万|#|2025-04-22|1.25亿|47.36%|463.11万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429103436a6cc867b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429103436a6cc867b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SMMT","LU2488822045.USD","LENZ","BK4139"],"gpt_icon":1},{"id":"1143954771","title":"异动 | 生物技术板块表现强势，SMMT涨超9%；美油短线走低","url":"https://stock-news.laohu8.com/highlight/detail?id=1143954771","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143954771?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:51","pubTimestamp":1745848265,"startTime":"0","endTime":"0","summary":"4月28日周一，美股生物技术板块表现强势，SMMT涨超9%，BioNTech涨近5%，百济神州、Moderna涨超2%，阿里拉姆制药涨近2%。美油短线走低0.54美元，下跌0.71%，现报62.57美元/桶。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT","BNTX"],"gpt_icon":0},{"id":"2530195357","title":"杰富瑞投资银行：维持Summit Therapeutics评级，由买入调整至买入评级, 目标价由31.00美元调整至44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530195357","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530195357?lang=zh_cn&edition=full","pubTime":"2025-04-26 05:17","pubTimestamp":1745615877,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行：维持Summit Therapeutics(SMMT.US)评级，由买入调整至买入评级, 目标价由31.00美元调整至44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042605204494e2f266&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042605204494e2f266&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LENZ"],"gpt_icon":0},{"id":"2530694968","title":"Summit Therapeutics Inc.4月24日成交额为2.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530694968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530694968?lang=zh_cn&edition=full","pubTime":"2025-04-25 10:33","pubTimestamp":1745548402,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，Summit Therapeutics Inc.成交额为2.66亿美元，成交额较昨日减少28.81%，当日成交量为762.62万股。Summit Therapeutics Inc.于2025年4月24日涨10.44%，报36.7美元，该股过去5个交易日涨59.22%，年初至今涨105.6%，过去60日涨56.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|2.66亿|-28.81%|762.62万|#|2025-04-23|3.74亿|199.84%|1179.65万|#|2025-04-22|1.25亿|47.36%|463.11万|#|2025-04-21|8463.59万|1.47%|340.02万|#|2025-04-17|8340.62万|-0.45%|344.71万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425103329a6c76c40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425103329a6c76c40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","SMMT","LU2488822045.USD"],"gpt_icon":0},{"id":"2529399341","title":"Summit Therapeutics Inc.4月21日成交额为8463.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529399341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529399341?lang=zh_cn&edition=full","pubTime":"2025-04-22 10:35","pubTimestamp":1745289304,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日，Summit Therapeutics Inc.成交额为8463.59万美元，成交额较昨日增加1.47%，当日成交量为340.02万股。Summit Therapeutics Inc.于2025年4月21日涨2.48%，报25.22美元，该股过去5个交易日涨8.52%，年初至今涨41.29%，过去60日涨2.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-21|8463.59万|1.47%|340.02万|#|2025-04-17|8340.62万|-0.45%|344.71万|#|2025-04-16|8378.62万|-51.17%|364.26万|#|2025-04-15|1.72亿|-16.08%|705.44万|#|2025-04-14|2.04亿|35.93%|817.33万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422103506a6c325e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422103506a6c325e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SMMT","BK4007","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.smmttx.com","stockEarnings":[{"period":"1week","weight":0.0844},{"period":"1month","weight":0.1166},{"period":"3month","weight":0.2611},{"period":"6month","weight":0.2216},{"period":"1year","weight":2.045},{"period":"ytd","weight":0.2883}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Summit Therapeutics Inc.于2013年11月22日在英格兰和威尔士注册成立，特拉华州的一家公司（“New Summit”）已成为该公司的后续发行方。该公司是一家生物制药公司，专注于发现、开发和商业化对患者、医生、护理人员和社会友好的药物疗法，旨在提高生活质量，延长潜在寿命，并解决严重的未满足的医疗需求。该公司的候选产品管线的设计目标是成为肿瘤治疗领域中对患者友好的、新时代的标准护理药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.119766},{"month":2,"riseRate":0.4,"avgChangeRate":0.024698},{"month":3,"riseRate":0.4,"avgChangeRate":0.028993},{"month":4,"riseRate":0.454545,"avgChangeRate":0.034483},{"month":5,"riseRate":0.545455,"avgChangeRate":0.099475},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.086722},{"month":7,"riseRate":0.636364,"avgChangeRate":0.073944},{"month":8,"riseRate":0.5,"avgChangeRate":0.002422},{"month":9,"riseRate":0.4,"avgChangeRate":0.095771},{"month":10,"riseRate":0.3,"avgChangeRate":-0.044184},{"month":11,"riseRate":0.4,"avgChangeRate":-0.012033},{"month":12,"riseRate":0.5,"avgChangeRate":0.394697}],"exchange":"NASDAQ","name":"Summit Therapeutics PLC","nameEN":"Summit Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Summit Therapeutics PLC,SMMT,Summit Therapeutics PLC股票,Summit Therapeutics PLC股票老虎,Summit Therapeutics PLC股票老虎国际,Summit Therapeutics PLC行情,Summit Therapeutics PLC股票行情,Summit Therapeutics PLC股价,Summit Therapeutics PLC股市,Summit Therapeutics PLC股票价格,Summit Therapeutics PLC股票交易,Summit Therapeutics PLC股票购买,Summit Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}